Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1988]
News [3223]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
The creation of SIOG, and a systematic review of the AML literature
Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA
The creation of SIOG, and a systematic review of the AML literature ( Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA )
22 Nov 2016
Multiple myeloma in the elderly
Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA
Multiple myeloma in the elderly ( Prof Tanya Wildes - Washington University School of Medicine, St. Louis, USA )
22 Nov 2016
Using adoptive cell therapy to fight cancer
Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA
Using adoptive cell therapy to fight cancer ( Prof Malcolm Brenner - Baylor College of Medicine, Houston, USA )
11 Nov 2016
What does palbociclib do and what side effects might we see?
Dr Alison Jones - The LOC, London, UK
What does palbociclib do and what side effects might we see? ( Dr Alison Jones - The LOC, London, UK )
8 Nov 2016
Overcoming painful bone disease in myeloma
Dr Nicola Giuliani - University of Parma, Parma, Italy
Overcoming painful bone disease in myeloma ( Dr Nicola Giuliani - University of Parma, Parma, Italy )
2 Nov 2016
History and progress of CD38 in myeloma
Dr Fabio Malavasi - University of Turin, Turin, Italy
History and progress of CD38 in myeloma ( Dr Fabio Malavasi - University of Turin, Turin, Italy )
2 Nov 2016
Maintenance therapy in young myeloma patients beneficial after autologous stem...
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Maintenance therapy in young myeloma patients beneficial after autologous stem cell transplant ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
2 Nov 2016
Better doctor-patient communication needed to improve myeloma outcomes
Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK
Better doctor-patient communication needed to improve myeloma outcomes ( Dr Karthik Ramasamy - Oxford University Hospital, Oxford, UK )
2 Nov 2016
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide
Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany
History of antiangiogenic drugs in multiple myeloma, starting with thalidomide ( Dr Jens Hillengaß - UniversitätsKlinikum Heidelberg, Heidelberg, Germany )
2 Nov 2016
Elderly patients should be treated based on biological age, not chronological
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
Elderly patients should be treated based on biological age, not chronological ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
2 Nov 2016
Cancer or amyloidosis?
Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center...
Cancer or amyloidosis? ( Dr Giovanni Palladini - Director, Amyloidosis Research and Treatment Center, Pavia, Italy )
2 Nov 2016
Monoclonal antibodies in multiple myeloma
Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France
Monoclonal antibodies in multiple myeloma ( Dr Phillippe Moreau - University Hospital of Nantes, Nantes, France )
1 Nov 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation